MedPath

comparison between two drugs for post spinal shivering

Not yet recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2021/09/036386
Lead Sponsor
Dr D Y Patil medical college
Brief Summary

Post spinal anaesthesia, Patients who developed either Grade 3 or 4 shivering lasting for a minimum period of 2 minutes, were included in the study. Injection nalbuphine 0.05mg/kg or Injection Tramadol 0.5 mg/kg were diluted to a volume of 10 ml in a 10 ml syringe and presented as coded syringes as per randomization list by an anesthesiologist who was unaware of the group allocation. This was then administered to the patient as a slow IV injection over a period of 10 minutes. All the hemodynamic parameters monitored.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients undergoing surgeries under spinal anaesthesia Stable asa I and II patients.

Exclusion Criteria
  • 1.Patients not willing to get enrolled in this study.
  • 2.Patients with ASA physical status III or more.
  • Patients below 18 years and above 60 years of age.
  • Patients posted for emergency procedures.
  • 5.Patients with uncontrolled systemic disorders like diabetes mellitus, heart disease, chronic hypertension, pulmonary disorders, etc.
  • 6.Patients with spine deformities or local skin interactions overlying the lumbar vertebral region.
  • 7.Patients with bleeding or coagulation disorders.
  • 9.Patients with history of alcohol or drug abuse.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Wrench grade -0-12 years
Ramsay Sedation score 1-22 years
Secondary Outcome Measures
NameTimeMethod
Effect of drugs from Onset of shivering post spinal and duration1 year and 2 years

Trial Locations

Locations (1)

Dr. D. Y. Patil medical hospital and research centre

🇮🇳

Pune, MAHARASHTRA, India

Dr. D. Y. Patil medical hospital and research centre
🇮🇳Pune, MAHARASHTRA, India
Dr Sonalika Tudimilla
Principal investigator
9676989293
sona3668@hotmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.